Transchem Quarterly Results for Trading Insights
TRANSCHEM • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹5 Cr
QMarch 2025
Transchem Quarterly Results Key Highlights
- Revenue of ₹11 Cr in March 2025 (+0.0% vs March 2025, +37.5% vs March 2024)
- Net Profit of ₹5 Cr in March 2025 (+0.0% vs March 2025, +25.0% vs March 2024)
- EBITDA of ₹7 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of -56.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹4.27 in March 2025 (+0.0% vs March 2025)
Transchem Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 10 | 11 | 8 | 4 | 7 | -9.1% | - |
| Net Profit (₹ Cr) | 4 | 5 | 4 | 1 | 3 | - | - |
| EBITDA (₹ Cr) | 5 | 7 | 6 | 3 | 4 | - | - |
| EPS (₹) | 3.10 | 4.27 | 3.43 | 1.01 | 2.34 | - | - |
| Operating Margin (%) | -44.0% | -56.0% | -423.0% | 0.0% | 0.0% | - | - |
Transchem Share Price Trend Around Quarterly Results
Visualize Transchem's 1-year price movement across quarterly results — ideal for logging trades in Transchem share price
chart using Tickjournal. All values in ₹.
Related Pages for Transchem
Additional stock information and data for TRANSCHEM
Revenue Trend (₹ Cr)
March 2023
4
March 2024
8
March 2025
11
2026
10
Net Profit Trend (₹ Cr)
March 2023
1
March 2024
4
March 2025
5
2026
4
Operating Margin Trend (%)
March 2023
0.0%
March 2024
-423.0%
March 2025
-56.0%
2026
-44.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Transchem quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹429,456.97 Cr | 1812.8 | 14,875 | 3,125 | +10.8% | - | 21.0% | 139.4 |
|
Divis Laboratories
Sept 2025 |
₹167,616.86 Cr | 6372.0 | 2,860 | 689 | +7.1% | - | 24.1% | 245.4 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹148,025.88 Cr | 4427.8 | 3,219 | 591 | +11.3% | - | 18.4% | 252.4 |
|
Dr Reddys Laborator…
Sept 2025 |
₹107,416.93 Cr | 1314.6 | 9,135 | 1,337 | +1.1% | - | 14.6% | 81.2 |
|
Cipla
Sept 2025 |
₹107,029.80 Cr | 1333.5 | 7,716 | 1,353 | +12.0% | - | 17.5% | 79.7 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores